{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T13:19:30Z","timestamp":1753881570503,"version":"3.41.2"},"reference-count":25,"publisher":"American Society for Microbiology","issue":"1","license":[{"start":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T00:00:00Z","timestamp":1642464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1128\/ASMCopyrightv2"},{"start":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T00:00:00Z","timestamp":1642464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2022,1,18]]},"abstract":"<jats:p>\n            Ceftolozane\/tazbactam (C\/T) is a potent anti-pseudomonal agent that has clinical utility against infections caused by non-carbapenemase, producing-carbapenem-resistant\n            <jats:named-content content-type=\"genus-species\">Pseudomonas aeruginosa<\/jats:named-content>\n            (non-CP-CR-PA). Accurate, precise, and reliable antimicrobial susceptibility testing (AST) is crucial to guide clinical decisions.\n          <\/jats:p>","DOI":"10.1128\/aac.01657-21","type":"journal-article","created":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T18:57:47Z","timestamp":1637002667000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":2,"title":["Real-World Performance of Susceptibility Testing for Ceftolozane\/Tazobactam against Non-Carbapenemase-Producing Carbapenem-Resistant Pseudomonas aeruginosa"],"prefix":"10.1128","volume":"66","author":[{"given":"Lina","family":"Rivas","sequence":"first","affiliation":[{"name":"Genomics &amp; Resistant Microbes (GeRM), Instituto de Ciencias e Innovaci\u00f3n en Medicina, Facultad de Medicina Cl\u00ednica Alemana, Universidad del Desarrollo, Santiago, Chile"},{"name":"Millennium Initiative for Collaborative Research On Bacterial Resistance (MICROB-R), Iniciativa Cient\u00edfica Milenio, Santiago, Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Alcalde-Rico","sequence":"additional","affiliation":[{"name":"Grupo de Resistencia Antimicrobiana en Bacterias Pat\u00f3genas y Ambientales, Facultad de Ciencias, Pontificia Universidad Cat\u00f3lica de Valpara\u00edso, Valpara\u00edso, Chile"},{"name":"Millennium Initiative for Collaborative Research On Bacterial Resistance (MICROB-R), Iniciativa Cient\u00edfica Milenio, Santiago, Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 R. W.","family":"Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Genomics &amp; Resistant Microbes (GeRM), Instituto de Ciencias e Innovaci\u00f3n en Medicina, Facultad de Medicina Cl\u00ednica Alemana, Universidad del Desarrollo, Santiago, Chile"},{"name":"Millennium Initiative for Collaborative Research On Bacterial Resistance (MICROB-R), Iniciativa Cient\u00edfica Milenio, Santiago, Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Victoria","family":"Moreno","sequence":"additional","affiliation":[{"name":"Hospital del Salvador, Santiago, Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela","family":"Rojas","sequence":"additional","affiliation":[{"name":"Hospital Padre Hurtado, Santiago, Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aniela","family":"Wozniak","sequence":"additional","affiliation":[{"name":"Laboratory of Microbiology, Escuela de Medicina, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"},{"name":"Clinical Laboratories Network, Red de Salud UC-CHRISTUS, Santiago, Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Garc\u00eda","sequence":"additional","affiliation":[{"name":"Millennium Initiative for Collaborative Research On Bacterial Resistance (MICROB-R), Iniciativa Cient\u00edfica Milenio, Santiago, Chile"},{"name":"Laboratory of Microbiology, Escuela de Medicina, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"},{"name":"Clinical Laboratories Network, Red de Salud UC-CHRISTUS, Santiago, Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Olivares-Pacheco","sequence":"additional","affiliation":[{"name":"Grupo de Resistencia Antimicrobiana en Bacterias Pat\u00f3genas y Ambientales, Facultad de Ciencias, Pontificia Universidad Cat\u00f3lica de Valpara\u00edso, Valpara\u00edso, Chile"},{"name":"Millennium Initiative for Collaborative Research On Bacterial Resistance (MICROB-R), Iniciativa Cient\u00edfica Milenio, Santiago, Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1518-2973","authenticated-orcid":true,"given":"William R.","family":"Miller","sequence":"additional","affiliation":[{"name":"Center for Antimicrobial Resistance and Microbial Genomics, Division of Infectious Diseases, McGovern Medical School, UTHealth, Houston, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesar A.","family":"Arias","sequence":"additional","affiliation":[{"name":"Center for Antimicrobial Resistance and Microbial Genomics, Division of Infectious Diseases, McGovern Medical School, UTHealth, Houston, Texas, USA"},{"name":"Center for Infectious Diseases, UTHealth School of Public Health, Houston, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0489-0712","authenticated-orcid":true,"given":"Ayesha","family":"Khan","sequence":"additional","affiliation":[{"name":"Center for Antimicrobial Resistance and Microbial Genomics, Division of Infectious Diseases, McGovern Medical School, UTHealth, Houston, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7870-1056","authenticated-orcid":true,"given":"Jos\u00e9 M.","family":"Munita","sequence":"additional","affiliation":[{"name":"Genomics &amp; Resistant Microbes (GeRM), Instituto de Ciencias e Innovaci\u00f3n en Medicina, Facultad de Medicina Cl\u00ednica Alemana, Universidad del Desarrollo, Santiago, Chile"},{"name":"Millennium Initiative for Collaborative Research On Bacterial Resistance (MICROB-R), Iniciativa Cient\u00edfica Milenio, Santiago, Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)62220-0"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105891"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01970-17"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01104-09"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw243"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx136"},{"key":"e_1_3_1_8_2","first-page":"68","article-title":"Antimicrobial activity of ceftolozane-tazobactam against multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa clinical isolates from a Spanish hospital","volume":"32","author":"L\u00f3pez-Calleja AI","year":"2019","unstructured":"L\u00f3pez-Calleja AI, Morilla ME, Nu\u00f1ez MR, Fern\u00e1ndez EM, Sahag\u00fan PJ, Garc\u00eda-Lechuz MJM, Ferrer CI, Vi\u00f1uelas BJ, Rezusta LA. 2019. Antimicrobial activity of ceftolozane-tazobactam against multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa clinical isolates from a Spanish hospital. Rev Esp Quimioter Publ of la Soc Esp Quimioter 32:68\u201372.","journal-title":"Rev Esp Quimioter Publ of la Soc Esp Quimioter"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz240"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2020.115302"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlaa129"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz416"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix014"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix182"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx424"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00717-18"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01633-17"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx253"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01093-17"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01637-19"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.01026-20"},{"key":"e_1_3_1_22_2","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01117-20","article-title":"Mechanisms of resistance to ceftolozane\/tazobactam in pseudomonas aeruginosa: results of the GERPA multicenter study","volume":"65","author":"Damien F","year":"2021","unstructured":"Damien F, Romain C, Maxime B, Emilie G, Pauline T, C\u00e9dric M, J\u00e9r\u00f4me L, Katy J, Patrick P. 2021. Mechanisms of resistance to ceftolozane\/tazobactam in pseudomonas aeruginosa: results of the GERPA multicenter study. Antimicrob Agents Chemother 65:e01117-20.","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01634-13"},{"key":"e_1_3_1_24_2","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing CLSI M100 Edition 30.","author":"The Clinical and Laboratory Standards Institute","year":"2020","unstructured":"The Clinical and Laboratory Standards Institute. 2020. Performance Standards for Antimicrobial Susceptibility Testing CLSI M100 Edition 30. Clinical and Laboratory Standards Institute, Wayne, PA."},{"key":"e_1_3_1_25_2","unstructured":"EUCAST. 2019. Breakpoint tables for interpretation of MICs and zone diameters v.9.0. EUCAST V\u00e4xj\u00f6 Sweden. https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Breakpoint_tables\/v_9.0_Breakpoint_Tables.pdf."},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01934-17"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01657-21","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01657-21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T23:36:15Z","timestamp":1645486575000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01657-21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,18]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1,18]]}},"alternative-id":["10.1128\/AAC.01657-21"],"URL":"https:\/\/doi.org\/10.1128\/aac.01657-21","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"type":"print","value":"0066-4804"},{"type":"electronic","value":"1098-6596"}],"subject":[],"published":{"date-parts":[[2022,1,18]]},"assertion":[{"value":"2021-08-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01657-21"}}